马拉松与D-核糖：诚志股份引领的一场产业“健康长跑”

Core Insights - The collaboration between Chengzhi Life and Beijing Sport University has successfully completed clinical exploration of D-Ribose for marathon athletes, demonstrating significant benefits for heart protection and athletic performance [1][2][4] - Chengzhi Co., as a leader in synthetic biology, has achieved a milestone in the industrial application of synthetic biology technology, contributing to global health industry transformation [1][2][10] Group 1: Clinical Research Findings - The study indicates that the Lipoz D-Ribose supplement significantly enhances heart protection, athletic performance, and fatigue recovery in marathon runners [2][5] - D-Ribose acts as a "cellular energy engine," directly participating in ATP synthesis and accelerating energy regeneration, which is crucial for endurance sports like marathons [5][6] - The clinical trials involved both middle-aged and young marathon runners, showing that D-Ribose supplementation reduces muscle damage and improves recovery speed [5][6] Group 2: Technological Advancements - Chengzhi Co. has developed a fermentation method for D-Ribose production, which is environmentally friendly and avoids toxic chemicals, achieving high purity and stability [7][10] - The company has established a comprehensive intellectual property network covering various aspects of D-Ribose production and application, positioning itself as a leader in the field [10][11] Group 3: Market Strategy and Achievements - Chengzhi Co. employs a "technology + market" dual-driven strategy, enhancing its global market presence through acquisitions and partnerships [10][11] - The company has seen a 50% increase in sales of Lipoz D-Ribose in 2024, with single product sales exceeding 100 million yuan, indicating strong market demand [11][12] - Chengzhi Co. has received multiple awards and recognitions, solidifying its position as a leading brand in the D-Ribose product category [11][12]